Hochschulschrift
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
190 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Die Habilitationsschrift besteht aus einem Text und 9 Aufsätzen, die zuvor in verschiedenen Publikationen veröffentlicht wurden
RWTH Aachen University, Habilitationsschrift, 2021
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2021]
Ähnliche Objekte (12)
Cardiovascular and cardiac therapeutic devices
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
MicroRNAs as therapeutic target in cardiovascular disease
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities
Novel p53-targeting therapeutic approaches for the treatment of high-risk ependymoma
From the pathophysiology of cardiovascular disease to new therapeutic approaches
Explaining the relation between Pathological Gambling and Depression: Rumination as an underlying common cause
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases
Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients
Cardiovascular and cardiac therapeutic devices
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
MicroRNAs as therapeutic target in cardiovascular disease
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities
Novel p53-targeting therapeutic approaches for the treatment of high-risk ependymoma
From the pathophysiology of cardiovascular disease to new therapeutic approaches
Explaining the relation between Pathological Gambling and Depression: Rumination as an underlying common cause
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases
Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients
Cardiovascular and cardiac therapeutic devices
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
MicroRNAs as therapeutic target in cardiovascular disease
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities
Novel p53-targeting therapeutic approaches for the treatment of high-risk ependymoma
From the pathophysiology of cardiovascular disease to new therapeutic approaches
Explaining the relation between Pathological Gambling and Depression: Rumination as an underlying common cause
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases
Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options